Leticia Bernal-Martínez
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Leticia Bernal-Martínez has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- De la Cruz- Ríos Paula
Mycology Reference Laboratory, National Center of Microbiology, Instituto de Salud Carlos III Majadahonda, 28222 Madrid, Spain
3 shared publications - Maria Jose Buitrago
Instituto de Salud Carlos III , Majadahonda, Madrid
3 shared publications - Laura Alcazar-Fuoli
Mycology Reference Laboratory. National Centre for Microbiology. Instituto de Salud Carlos III, Madrid, Spain
2 shared publications - Sara Gago
University of Manchester
2 shared publications - Sheila Ortega
Mycology Reference Laboratory, National Center of Microbiology, Instituto de Salud Carlos III Majadahonda, 28222 Madrid, Spain
2 shared publications - Viedma-Blanco Raúl
Mycology Reference Laboratory, National Center of Microbiology, Instituto de Salud Carlos III Majadahonda, 28222 Madrid, Spain
2 shared publications
Latest Publications
- Open Access
- 12 June 2025
- Published by MDPI AG in Journal of Fungi
- Vol. 11 (6) , 448
Usefulness of Serum as a Non-Invasive Sample for the Detection of Histoplasma capsulatum Infections: Retrospective Comparative Analysis of Different Diagnostic Techniques and Quantification of Host Biomarkers
Diagnosis of histoplasmosis is challenging. A rapid, sensitive, and specific method is essential. Serum is a non-invasive and easy sample to obtain in any hospital. The diagnostic accuracy of different techniques that use serum has been evaluated. Forty-one serum samples from patients with proven or probable histoplasmosis were analyzed. Different diagnostic techniques based on the detection of antibodies (ID Fungal Antibody System), antigens (Histoplasma GM EIA and PlateliaTM Aspergillus Ag), and DNA (“in-house” real-time PCR (RT-PCR) were tested and compared. Additionally, the quantification of cytokines and biomarkers related to histoplasmosis was performed. Global results from 27 samples in which all the tests were performed showed that the sensitivity of the Histoplasma GM EIA kit was 87.5% in patients with disseminated infection and HIV as an underlying disease; in immunocompetent (IC) patients, it was 54.5%. The detection of Histoplasma spp. with the ID Fungal Antibody System was positive in 90.9% of IC and in 62.5% of HIV patients. The Platelia-Asp kit had a low performance in both groups of patients (37.5% in HIV and 9% in non-HIV), and, finally, RT-PCR was better in immunosuppressed patients (44% in HIV vs. 27% in non-HIV). The combination of diagnostic techniques increased the detection of Histoplasma infection in inmunosupressed patients. Overall, patient groups infected with H. capsulatum (Hc) showed higher IL-8, IL-6, IL-1β, TNF-α, and IL-18 median values compared to non-Hc-infected controls. The effectiveness of diagnostic techniques on serum samples is highly influenced by the patient’s clinical presentation and underlying condition. Consequently, a thorough assessment of the patient’s clinical presentation and disease phenotype is crucial in selecting the most suitable diagnostic method.
- 12 June 2025
- Published by MDPI AG in Journal of Fungi
- Vol. 11 (6) , 448
Open AccessUsefulness of Serum as a Non-Invasive Sample for the Detection of Histoplasma capsulatum Infections: Retrospective Comparative Analysis of Different Diagnostic Techniques and Quantification of Host Biomarkers
Diagnosis of histoplasmosis is challenging. A rapid, sensitive, and specific method is essential. Serum is a non-invasive and easy sample to obtain in any hospital. The diagnostic accuracy of different techniques that use serum has been evaluated. Forty-one serum samples from patients with proven or probable histoplasmosis were analyzed. Different diagnostic techniques based on the detection of antibodies (ID Fungal Antibody System), antigens (Histoplasma GM EIA and PlateliaTM Aspergillus Ag), and DNA (“in-house” real-time PCR (RT-PCR) were tested and compared. Additionally, the quantification of cytokines and biomarkers related to histoplasmosis was performed. Global results from 27 samples in which all the tests were performed showed that the sensitivity of the Histoplasma GM EIA kit was 87.5% in patients with disseminated infection and HIV as an underlying disease; in immunocompetent (IC) patients, it was 54.5%. The detection of Histoplasma spp. with the ID Fungal Antibody System was positive in 90.9% of IC and in 62.5% of HIV patients. The Platelia-Asp kit had a low performance in both groups of patients (37.5% in HIV and 9% in non-HIV), and, finally, RT-PCR was better in immunosuppressed patients (44% in HIV vs. 27% in non-HIV). The combination of diagnostic techniques increased the detection of Histoplasma infection in inmunosupressed patients. Overall, patient groups infected with H. capsulatum (Hc) showed higher IL-8, IL-6, IL-1β, TNF-α, and IL-18 median values compared to non-Hc-infected controls. The effectiveness of diagnostic techniques on serum samples is highly influenced by the patient’s clinical presentation and underlying condition. Consequently, a thorough assessment of the patient’s clinical presentation and disease phenotype is crucial in selecting the most suitable diagnostic method.
- Open Access
- 22 April 2025
- Published by MDPI AG in Preprints.org
Usefulness of Serum as a Non-Invasive Sample for the Detection of Histoplasma capsulatum Infections: Comparative Analysis of Different Diagnostic Techniques
Diagnosis of histoplasmosis is challenging. A rapid, sensitive, and specific method is essential. Serum is a non-invasive and easy sample to obtain in any hospital. The diagnostic accuracy of different techniques that use serum has been evaluated. Forty one serum samples from patients with proven or probable histoplasmosis were analyzed. Different techniques based on the detection of antibodies, (ID Fungal Antibody System), antigens (Histoplasma GM EIA and Platelia TM Aspergillus Ag) and DNA (“in house “real time PCR (RT-PCR) have been tested. Additionally, 36 sera samples were selected for the quantification of cytokines and biomarkers related to histoplasmosis. The sensitivity of the Histoplasma GM EIA kit was 94% in patients with disseminated infection and HIV as underlying disease, in immunocompetent (IC) patients it was 66%. The detection of Histoplasma spp. with the ID Fungal Antibody System was positive in 84% of IC and in 68% of HIV patients. The Platelia-Asp kit had a low performance in both groups of patients (38% HIV and 21% non-HIV) and, finally, RT-PCR was better in immunosuppressed patients (47% HIV vs. 26% non-HIV). Combination of diagnostic tecniques increased the detection Histoplasma infection in inmunosupressed patients. Overall, patient groups infected with H. capsulatum (Hc) showed higher IL-8, IL-6, IL-1β, TNF-α, IL-18 median values compared to not Hc infected controls. The effectiveness of diagnostic techniques on serum samples is highly influenced by the patient's clinical presentation and underlying condition. Consequently, a thorough assessment of the patient's clinical presentation and disease phenotype is crucial in selecting the most suitable diagnostic method.
- 22 April 2025
- Published by MDPI AG in Preprints.org
Open AccessUsefulness of Serum as a Non-Invasive Sample for the Detection of Histoplasma capsulatum Infections: Comparative Analysis of Different Diagnostic Techniques
Diagnosis of histoplasmosis is challenging. A rapid, sensitive, and specific method is essential. Serum is a non-invasive and easy sample to obtain in any hospital. The diagnostic accuracy of different techniques that use serum has been evaluated. Forty one serum samples from patients with proven or probable histoplasmosis were analyzed. Different techniques based on the detection of antibodies, (ID Fungal Antibody System), antigens (Histoplasma GM EIA and Platelia TM Aspergillus Ag) and DNA (“in house “real time PCR (RT-PCR) have been tested. Additionally, 36 sera samples were selected for the quantification of cytokines and biomarkers related to histoplasmosis. The sensitivity of the Histoplasma GM EIA kit was 94% in patients with disseminated infection and HIV as underlying disease, in immunocompetent (IC) patients it was 66%. The detection of Histoplasma spp. with the ID Fungal Antibody System was positive in 84% of IC and in 68% of HIV patients. The Platelia-Asp kit had a low performance in both groups of patients (38% HIV and 21% non-HIV) and, finally, RT-PCR was better in immunosuppressed patients (47% HIV vs. 26% non-HIV). Combination of diagnostic tecniques increased the detection Histoplasma infection in inmunosupressed patients. Overall, patient groups infected with H. capsulatum (Hc) showed higher IL-8, IL-6, IL-1β, TNF-α, IL-18 median values compared to not Hc infected controls. The effectiveness of diagnostic techniques on serum samples is highly influenced by the patient's clinical presentation and underlying condition. Consequently, a thorough assessment of the patient's clinical presentation and disease phenotype is crucial in selecting the most suitable diagnostic method.
- Open Access
- 27 April 2021
- Published by MDPI AG in Journal of Fungi
- Vol. 7 (5) , 336
Differential Diagnosis of Fungal Pneumonias vs. Tuberculosis in AIDS Patients by Using Two New Molecular Methods
Opportunistic fungal pneumonias (OFP) are the main cause of death in AIDS patients worldwide. Diagnosis of these infections is often late as tuberculosis (TB) is frequently the first suspicion. In addition, diagnostic tools have limitations and are unavailable in disadvantaged regions. To perform the differential diagnosis of the main fungi causing OFP in AIDS patients (Histoplasma capsulatum, Cryptococcus neoformans/C. gattii and Pneumocystis jirovecii) vs. the Mycobacterium tuberculosis complex (MTBC), two new assays were developed: (i) a multiplex real-time PCR (MRT-PCR) and (ii) a simple and cost-effective method based on real-time PCR and the analysis of melting curves after amplification (MC-PCR). Both of the techniques were optimized and standardized “in vitro”, showing a suitable reproducibility (CV ranged between 1.84 and 3.81% and 1.41 and 4.83%, respectively), a 100% specificity and detection limits between 20 and 2 fg of genomic DNA per 20 µL of reaction. A validation study was performed by retrospectively using 42 clinical samples from 37 patients with proven fungal infection or TB, and 33 controls. The overall sensitivity for the MRT-PCR assay and the MC-PCR assay was 88% and 90.4%, respectively. Both techniques were fast, sensitive and reproducible, allowing for the detection of these pathogens and the performance of a differential diagnosis.
- 27 April 2021
- Published by MDPI AG in Journal of Fungi
- Vol. 7 (5) , 336
Open AccessDifferential Diagnosis of Fungal Pneumonias vs. Tuberculosis in AIDS Patients by Using Two New Molecular Methods
Opportunistic fungal pneumonias (OFP) are the main cause of death in AIDS patients worldwide. Diagnosis of these infections is often late as tuberculosis (TB) is frequently the first suspicion. In addition, diagnostic tools have limitations and are unavailable in disadvantaged regions. To perform the differential diagnosis of the main fungi causing OFP in AIDS patients (Histoplasma capsulatum, Cryptococcus neoformans/C. gattii and Pneumocystis jirovecii) vs. the Mycobacterium tuberculosis complex (MTBC), two new assays were developed: (i) a multiplex real-time PCR (MRT-PCR) and (ii) a simple and cost-effective method based on real-time PCR and the analysis of melting curves after amplification (MC-PCR). Both of the techniques were optimized and standardized “in vitro”, showing a suitable reproducibility (CV ranged between 1.84 and 3.81% and 1.41 and 4.83%, respectively), a 100% specificity and detection limits between 20 and 2 fg of genomic DNA per 20 µL of reaction. A validation study was performed by retrospectively using 42 clinical samples from 37 patients with proven fungal infection or TB, and 33 controls. The overall sensitivity for the MRT-PCR assay and the MC-PCR assay was 88% and 90.4%, respectively. Both techniques were fast, sensitive and reproducible, allowing for the detection of these pathogens and the performance of a differential diagnosis.